Estrella Immunopharma (ESLAW) Q2 2026 Earnings

3JunConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.19
-0.15
-0.11
-0.07

Details

Expected EPS
-0.084
Actual EPS
N/A
Surprise EPS
0.08
Surprise Percent
+100%

Description

Estrella Immunopharma (ESLAW) will report earnings of for Q2 2026 on June 03, 2026.

0 Comments

Share your thoughts